April 03, 2014
In Re: Aggrenox Antitrust Litigation
Case Number:
3:14-md-02516
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Hurwitz Sagarin
- Stoll Berne
- Reinhardt Wendorf
- Ahern & Associates
- Quinn Connor Weaver
- Capozzi Adler
- Blank Rome
- Levin Sedran
- Goodwin Procter
- Motley Rice
- Milberg Coleman
- Hilliard & Shadowen
- Smith Segura Raphael & Leger
- Girard Sharp
- Zayas Law Firm
- Cohen Placitella
- Roche Pia LLC
- Baker & Miller
- Barrett Johnston
- Garwin Gerstein
- Odom & Des Roches
- Spector Roseman
- Heins Mills
- Miller Shah LLP
- Hayber McKenna
- King & Spalding
- Pomerantz LLP
- Wiley Rein
- Faruqi & Faruqi
- Hausfeld LLP
- Cohen Milstein
- Lockridge Grindal
- Shipman & Goodwin
- Bass Berry
- Hagens Berman
- Simmons Hanly
- Hangley Aronchick
- Cowdery Murphy
- Nussbaum Law Group
- Brenner Saltzman
- Scott&Scott
- Gibson Dunn
- Pullman & Comley
- Nixon Peabody
- Paul Hastings
- Jones Day
- Taus Cebulash
- Day Pitney
- Lowey Dannenberg
- Carmody Torrance Sandak & Hennessey LLP
- DiCello Levitt
- Ballard Spahr
- Heim Payne
- Norton Rose
- Stevens & Lee
- Winstead PC
- Sperling Kenny
- Berger Montague
- Baker Donelson
- Zimmerman Reed
- Glancy Prongay
- Connolly Wells
- Lauletta Birnbaum
- Grant & Eisenhofer
- Labaton Keller
- Latham & Watkins
- White & Case
Companies
- Florida Blue
- Association for Accessible Medicines
- The Kroger Co.
- Aetna Inc.
- Gyma Laboratories of America Inc.
- Boehringer Ingelheim Corp.
- Bi-Lo
- The Cigna Group
- Humana Inc.
- Rochester Drug Cooperative Inc.
- Boehringer Ingelheim Vetmedica Inc.
- International Union of Painters & Allied Trades
- Pirelli & Co.
- CVS Health Corp.
- Safeway Inc.
- BlueCross BlueShield of Tennessee Inc.
- H‑E‑B LP
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 29, 2019
Allergan's $750M Deal Among Pharma's Top Antitrust Payouts
A $750 million settlement this week by Allergan to avert an antitrust trial involving Alzheimer's drug Namenda is among the most eye-popping sums ever shelled out by a drugmaker for allegedly thwarting generic competition.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login